Zota Health Care Ltd. Updates Shareholders on Tax Deduction for Final Dividend
Zota Health Care announced its Board recommended a 10% final dividend (Re. 1 per share) for FY2025-26. Shareholders must provide documentation by Sept 30, 2026, for tax deduction at source (TDS) calculations. TDS rates vary for resident and non-resident shareholders based on PAN, Aadhaar linkage, and DTAA provisions. Dividend payment is scheduled for on or after Sept 30, 2026.
The announcement provides crucial information for shareholders regarding tax deductions on their dividend income, which directly affects their net payout. It also clarifies procedures and deadlines, impacting shareholder actions.
The announcement is a routine communication regarding tax implications on dividend payouts and does not contain any new financial performance data or significant business updates that would strongly influence the sentiment.
Zota Health Care Limited has issued a communication to its shareholders regarding the tax deduction at source (TDS) on the final dividend for the financial year 2025-26. The Board of Directors recommended a final dividend of 10%, or Re. 1 per equity share of face value Rs. 10, at their meeting on May 22, 2026. This dividend is subject to shareholder approval at the upcoming Annual General Meeting (AGM).
The company has detailed the TDS provisions as per the Income Tax Act, 2025, for both resident and non-resident shareholders. For resident individual shareholders, tax will be deducted at 10% if the dividend amount exceeds Rs. 10,000 and PAN is available and valid. No tax will be deducted if the aggregate dividend paid during the tax year 2026-27 does not exceed Rs. 10,000 or if Form 121 is submitted with prescribed conditions. A 20% tax will be deducted if PAN is not available or invalid, or if PAN is not linked with Aadhaar.
Special provisions are outlined for resident non-individual shareholders such as insurance companies, mutual funds, AIFs, and NPS Trusts, who may be exempt from TDS upon providing necessary documentation. For non-resident shareholders, tax will be deducted at 20% plus applicable surcharge and cess, or at rates specified in a Double Tax Avoidance Agreement (DTAA) certificate if more beneficial and proper documentation is provided. Shareholders are required to submit necessary details and documents by September 30, 2026, to enable the company to determine the correct TDS rate. The dividend, once approved, will be paid on or after September 30, 2026.
What to do with a filing like this
Zota Health Care LImited filed this with the NSE as a statutory disclosure, categorised under dividend. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Zota Health Care LImited. Read the original for the full detail.